Hypertrophic Cardiomyopathy (HCM) • LITFL • ECG Library …
Oct 8, 2024 · Hypertrophic Cardiomyopathy (HCM) results in characteristic ECG changes of "dagger-like" Q waves and large precordial voltages
Hypertrophic Cardiomyopathy (HCM) & Hypertrophic …
The prevalence in a Western population is approximately 0.2%. Hypertrophic cardiomyopathy is one of the most common causes of cardiac arrest and sudden cardiac death (SCD) among young individuals. Among athletes, hypertrophic cardiomyopathy is the most common cause of …
Hypertrophic Obstructive Cardiomyopathy (HOCM) ECG Review
Hypertrophic Obstructive Cardiomyopathy (HOCM) ECG Review
Hypertrophic Cardiomyopathy • LITFL • CCC Cardiology
Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac disorders (affecting ~ 1 in 500 people) and is the number one cause of sudden cardiac death in young athletes. Annual mortality is estimated at 1-2 %.
Hypertrophic Obstructive Cardiomyopathy - StatPearls - NCBI Bookshelf
Oct 31, 2022 · Hypertrophic obstructive cardiomyopathy (HOCM), historically referred to as idiopathic hypertrophic subaortic stenosis, is a relatively common disorder. HOCM is a significant cause of sudden cardiac death in young people, including well-trained athletes, and affects men and women equally across all races.
2020 AHA/ACC Guideline for the Diagnosis and Treatment of …
Nov 20, 2020 · Since the original clinical description of HCM >60 years ago, various names have been used to describe this disease, including idiopathic hypertrophic subaortic stenosis and hypertrophic obstructive cardiomyopathy.
Hypertrophic cardiomyopathy: Clinical manifestations, …
Oct 4, 2022 · Hypertrophic cardiomyopathy (HCM) is a genetically determined heart muscle disease most often (60 to 70 percent) caused by mutations in one of several sarcomere genes which encode components of the contractile apparatus of the heart.
2020 AHA/ACC Guideline for Hypertrophic Cardiomyopathy: Key ...
Nov 20, 2020 · In first-degree relatives of patients with HCM, clinical screening should include ECG and TTE during the initial evaluation followed by periodic follow-up according to their age (1-2 years in adolescents, 3-5 years in adults) or if clinical status changes.
2020 AHA/ACC Guideline for the Diagnosis and Treatment of …
Nov 20, 2020 · This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use.
Hypertrophic Cardiomyopathy - Hypertrophic Cardiomyopathy …
Less common infiltrative cardiac disorders such as Anderson-Fabry disease and amyloid heart disease may mimic findings of hypertrophic cardiomyopathy. ECG and 2-dimensional echocardiography and/or MRI (the best noninvasive confirmatory tests) are done.
- Some results have been removed